GSK is one of the pharma industry's top vaccine producers, giving Affinivax' shot the marketing muscle it will need to challenge Pfizer's Prevnar 13 and Prevnar 20 products – targeting 13 and 20 ...

GSK has garnered FDA approval for its pentavalent meningococcal vaccine Penmenvy, tipped as one of its major launches for 2025 and a rival to Pfizer's first-to-market Penbraya. The shot protects ...

The GlaxoSmithKline Capital PLC-Bond has a maturity date of 12/20/2027 and offers a coupon of 3.3750%. The payment of the coupon will take place 1,0 times per Year on the 20.12.. The ...

GlaxoSmithKline Pharmaceuticals, operating in the Pharmaceuticals sector and classified as a Largecap on the BSE, currently has its share price at ₹3015.9. The stock has experienced fluctuations ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or ...

Option Chain is currently not available. Nasdaq provides call and put options information of stocks. Financial analysts and individual investors can rely on the chain to gauge the stock's ...